Pharma 2020: The Future of R&D

27 - 29 Mar 2018, Vienna

Pharma 2020: The Future of R&D Summit will gather the best professionals within research and development of new drugs in pharma industry in Vienna this coming March. One of the main focuses of this meeting is the Open Innovation as a new business model in R&D. Join us and find out how the top pharma companies use the collaborative approaches to boost drug discovery, or which technologies will be the future of drug development. We will discuss innovations such as Artificial Intelligence, robotics, machine learning, imaging, and many others. Do not forget to highlight the dates 27 - 29 March 2018 in your calendar and book the flight to Vienna as soon as possible. We are looking forward to meeting you in the best R&D in Pharma Summit soon! 

 

Key Speakers

Peter Ettmayer 

Director New Therapeutic Discovery

Boehringer Ingelheim

 

Mikhail Kalinichev

Director , in vivo Neurology
Ipsen

Mathew Woodmark
Director Research Informatics
MedImmune

Ulrich Betz
Vice President Innovation, Head of Department Innovation Incubator
Merck

Yong Xue 
Clinical Research Director
Sanofi Genzyme

Antoine Brill 
Scientific Director Research and Parterships
Servier


Key topics

  • Open innovation as a new business model in Pharma R&D
  • External collaboration and partnerships in R&D
  • The Innovative Medicine Initiative and the changes in drug discovery
  • New technologies in drug discovery – imaging, robotics, and augmented intelligence
  • Impact of pre-clinical studies on therapeutic strategy of the drug
  • Strategic Data integration
  • Artificial Intelligence and Machine Learning in R&D
  • China as one of the strategically important markets for new drug research
  • Special innovation activities Merck is running on the occasion of its 350th anniversary
   

Who Should attend

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors, and Heads of departments from pharmaceutical industry / industries involved in:

  • R&D
  • Drug Discovery
  • Drug Development
  • Clinical Development 
  • Open Innovation
  • Early research and development
  • Innovation
  • External Innovation
  • External collaboration
  • Alliance Management and Partnerships
  • Artificial Intelligence
  • Machine Learning
  • Translational Medicine
  • R&D Information Technology
  • R&D Analytics
  • New Technology
  • Bioinformatics


Register for event

Video

Contact

Allan Lloyds Group
Trnavska cesta 82, 821 02 Bratislava, Slovakia

+421 221 025 322

info@allanlloyds.com

Follow us